NVO
Price
$69.32
Change
+$0.15 (+0.22%)
Updated
Jul 7 closing price
Capitalization
316.35B
29 days until earnings call
ORMP
Price
$2.16
Change
-$0.02 (-0.92%)
Updated
Jul 7 closing price
Capitalization
88.24M
36 days until earnings call
Interact to see
Advertisement

NVO vs ORMP

Header iconNVO vs ORMP Comparison
Open Charts NVO vs ORMPBanner chart's image
Novo-Nordisk A/S
Price$69.32
Change+$0.15 (+0.22%)
Volume$7.31M
Capitalization316.35B
Oramed Pharmaceuticals
Price$2.16
Change-$0.02 (-0.92%)
Volume$42.66K
Capitalization88.24M
NVO vs ORMP Comparison Chart in %
Loading...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVO vs. ORMP commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVO is a Buy and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 08, 2025
Stock price -- (NVO: $69.32 vs. ORMP: $2.16)
Brand notoriety: NVO and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVO: 75% vs. ORMP: 58%
Market capitalization -- NVO: $316.35B vs. ORMP: $88.24M
NVO [@Biotechnology] is valued at $316.35B. ORMP’s [@Biotechnology] market capitalization is $88.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVO’s FA Score shows that 2 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • NVO’s FA Score: 2 green, 3 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, NVO is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVO’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • NVO’s TA Score: 3 bullish, 6 bearish.
  • ORMP’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, NVO is a better buy in the short-term than ORMP.

Price Growth

NVO (@Biotechnology) experienced а +0.43% price change this week, while ORMP (@Biotechnology) price change was -4.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.70%. For the same industry, the average monthly price growth was +14.37%, and the average quarterly price growth was +1.06%.

Reported Earning Dates

NVO is expected to report earnings on Aug 06, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+5.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVO($316B) has a higher market cap than ORMP($88.2M). ORMP has higher P/E ratio than NVO: ORMP (20.91) vs NVO (18.71). ORMP YTD gains are higher at: -9.917 vs. NVO (-18.292). NVO has higher annual earnings (EBITDA): 147B vs. ORMP (-21.53M). NVO has more cash in the bank: 41.6B vs. ORMP (131M). ORMP has less debt than NVO: ORMP (301K) vs NVO (119B). NVO has higher revenues than ORMP: NVO (303B) vs ORMP (2M).
NVOORMPNVO / ORMP
Capitalization316B88.2M358,277%
EBITDA147B-21.53M-682,895%
Gain YTD-18.292-9.917184%
P/E Ratio18.7120.9190%
Revenue303B2M15,150,000%
Total Cash41.6B131M31,756%
Total Debt119B301K39,534,884%
FUNDAMENTALS RATINGS
NVO vs ORMP: Fundamental Ratings
NVO
ORMP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
58
Fair valued
PROFIT vs RISK RATING
1..100
64100
SMR RATING
1..100
1494
PRICE GROWTH RATING
1..100
6362
P/E GROWTH RATING
1..100
9853
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVO's Valuation (26) in the Pharmaceuticals Major industry is in the same range as ORMP (58) in the Pharmaceuticals Other industry. This means that NVO’s stock grew similarly to ORMP’s over the last 12 months.

NVO's Profit vs Risk Rating (64) in the Pharmaceuticals Major industry is somewhat better than the same rating for ORMP (100) in the Pharmaceuticals Other industry. This means that NVO’s stock grew somewhat faster than ORMP’s over the last 12 months.

NVO's SMR Rating (14) in the Pharmaceuticals Major industry is significantly better than the same rating for ORMP (94) in the Pharmaceuticals Other industry. This means that NVO’s stock grew significantly faster than ORMP’s over the last 12 months.

ORMP's Price Growth Rating (62) in the Pharmaceuticals Other industry is in the same range as NVO (63) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew similarly to NVO’s over the last 12 months.

ORMP's P/E Growth Rating (53) in the Pharmaceuticals Other industry is somewhat better than the same rating for NVO (98) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew somewhat faster than NVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVOORMP
RSI
ODDS (%)
Bearish Trend 6 days ago
55%
Bearish Trend 6 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
73%
Bearish Trend 6 days ago
84%
Momentum
ODDS (%)
Bearish Trend 6 days ago
55%
Bullish Trend 6 days ago
80%
MACD
ODDS (%)
Bearish Trend 6 days ago
62%
Bullish Trend 6 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
67%
Bullish Trend 6 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
60%
Bearish Trend 6 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
67%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 19 days ago
57%
Bearish Trend 12 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
53%
Bearish Trend 7 days ago
82%
Aroon
ODDS (%)
Bullish Trend 6 days ago
59%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCCT11.71N/A
N/A
First Community Corp. (TN)
KAEPF11.90N/A
N/A
Kansai Electric Power Co., Inc. (The)
SBFFF26.31N/A
N/A
SBM Offshore NV
BORTP31.99N/A
N/A
Bank of Botetourt (Buchanan, VA)
WLDBF1.55-0.07
-4.02%
WILDBRAIN LTD.

NVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been loosely correlated with BCAB. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NVO jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-0.93%
BCAB - NVO
38%
Loosely correlated
-5.43%
TECH - NVO
36%
Loosely correlated
-0.08%
GMAB - NVO
33%
Loosely correlated
-0.68%
IONS - NVO
33%
Poorly correlated
-1.35%
ROIV - NVO
32%
Poorly correlated
+0.18%
More

ORMP and

Correlation & Price change

A.I.dvisor tells us that ORMP and FULC have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORMP and FULC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.93%
FULC - ORMP
28%
Poorly correlated
-0.14%
APLS - ORMP
28%
Poorly correlated
+2.47%
PRLD - ORMP
27%
Poorly correlated
-0.76%
NVO - ORMP
27%
Poorly correlated
-0.93%
SONN - ORMP
27%
Poorly correlated
-5.54%
More